Inpharma Weekly

, Volume 754, Issue 1, pp 6–7 | Cite as

CQA 206291: has antiparkinsonian activity as monotherapy, and as additional therapy in patients with insufficient response to levodopa

Newsletter Article

Keywords

Levodopa Orthostatic Hypotension Dopamine Agonist Evaluable Patient Additional Therapy 

Copyright information

© Adis International Ltd 1990

Personalised recommendations